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Simple Summary: Surgical castration is an ongoing problem in pig production, especially in breeds
reared until older ages, like the Bísaro pig. To avoid this technique, three immunocastration protocols
with different numbers of injections and times of inoculation were tested. Scrotal measurements were
used to attest their effectiveness. The best protocol was the one with three administrations starting at
three months old. It was able to maintain the testis size below puberty size for 16 weeks following
the last injection.
Abstract: This study aimed to find a suitable immunocastration protocol for male Bísaro pigs (BP) due
to the breed and production system particularities. Twenty-five male BP were treated with Improvac®
according to three protocols: using two (GrpE2 and L2) or three vaccinations (GrpL3) and starting at
9 (GrpE2) or 13 weeks old (GrpL2 and L3). Eleven animals were kept as intact males (GrpC). Scrotal
measurements and the morphometry of the testes and epididymides collected at slaughter were used
to survey the effectiveness of the immunocastration compared with the age-matched intact controls.
Animals in groups E2 and L3 were kept until 57 weeks, after a second vaccination cycle at 49 and
53 weeks of age. Scrotal dimensions decreased to almost initial values in treated animals until 17
(GrpE2) and 21 weeks (GrpL2 and L3), thereafter increasing to post-pubertal values until around 29
or 37 weeks of age for groups E2 and L2, respectively, but only at 41 weeks in group L3. Between
41 and 49 weeks, scrotal dimensions were similar in treated and control animals, decreasing to the
predicted pre-puberty size after the second cycle of vaccination. This study suggests the most suited
protocol for males slaughtered at older ages includes three administrations of Improvac® starting at
3 months of age, followed by a second vaccination cycle.
Keywords: boar; improvac; scrotal dimensions; immunosuppression; pork
1. Introduction
Animal welfare, in particular surgical castration, has been a major concern for the
European pork industry in the last decade. In 2010, the European Commission issued a
declaration on alternatives to the surgical castration of pigs [1] and committed to stopping
castration by 2018. Goals from this declaration are far from being met [2], and the EU has
not yet banned pig castration. As this procedure is traditionally done without anesthesia
or analgesia, it is undeniably associated with pain, stress, and the risk of infection, thus
promoting the use of alternatives [3–6]. Consumers also share similar welfare concerns [7].
A promising alternative is immunocastration, which is known for suppressing gonadal
activity and producing carcasses without boar taint [8,9]. This procedure is based on
the administration of a gonadotropin-releasing hormone analogue (GnRH) conjugated
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to a protein [10], which drives the formation of antibodies against GnRH, thereby pre-
venting luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion [11].
Consequently, the secretion of testicular steroids, such as androstenone, one of the main
compounds responsible for boar taint [12], is reduced. Another compound is skatole, pro-
duced in the hindgut by microbial activity from tryptophan and its metabolism modulated
by gonadal steroids in the liver [13]. Besides this, immunocastrated animals will have
reduced fat accumulation compared to surgically castrated ones. The differences in fat
accumulation have been recently associated with FSH regulation of the genes balancing
lipogenesis/lipolysis. In surgically castrated pigs, high FSH levels drive a reduction of
lipolysis, favoring fat accumulation, while in immunocastrated pigs, the reduced FSH
levels have the opposite effect [14]. This technique appears to be broadly accepted as a
valid alternative for local breeds [15,16] preferred by consumers regarding their perceived
health-related risks [17,18], with no significant consequences for the meat quality or cured
products [16,19,20].
Even so, immunocastration still presents many uncertainties. In the case of Bísaro
pigs (BP), like some other breeds produced in traditional extensive systems in the Mediter-
ranean area, the animals are usually reared up to ages of more than a year old, often
in mixed gender groups. Moreover, many systems are based on or include periods of
extensive grazing [21]. These periods entail limited handling facilities and the risk of the
unintentional mating of females with male cohorts or wild boars. These factors suggest
that immunocastration should start as early as is required and be maintained for longer
periods, in contrast with the manufacturer’s short-term protocol for industrial systems.
The reproductive capability of male pigs can be predicted by scrotal measurements [15,
22,23]. Puberty is a period characterized by rapid reproductive development and may
be perceived by the increase in testicular growth. On the other hand, the effectiveness of
immunocastration can be predicted indirectly through testicular measurements [24–26]
or the development of sexual accessory glands [27], as immunocastrated animals have less
developed genital organs [28]. The morphometric analysis of scrotal gonads, considering
pre- and post-pubertal values, can then be a useful tool when evaluating the effectiveness
of immunocastration protocols.
The Bísaro pig is one of the most representative Portuguese autochthonous breeds [29,30]
and is known for its robustness and reported meat quality [31]. The BP is sexually preco-
cious, reaching puberty between 14 and 17 weeks old [32]. If intended for the industry of
cured value-added products, it is mainly reared up to 13 months old. Yet today, a major
limitation for the growth of this industry is that an increasing number of animals are
slaughtered at younger ages, before or shortly after weaning (approx. 45 d) [21], as a result
of various difficulties in complying with the castration restrictions introduced by the EU in
2008 and thus in rearing animals to older ages. This essay aims to define an appropriate
immunocastration protocol to overcome this issue, allowing for an extended suppression
period of testicular function with a minimal number of administrations. It will also allow
the establishment of extended protocols suited for other autochthonous breeds reared in
similar non-industrial systems.
2. Materials and Methods
2.1. Vaccination Protocols
Thirty-nine male Bísaro pigs were used in this study. Twenty-eight were randomly
assigned to three treatment groups and one control group. Animals in the treatment group
were vaccinated against GnRH with Improvac® (Zoetis) with the standard dosing regimen
(2 mL subcutaneous) using different protocols (Figure 1). In group E2, two animals died
at the beginning of the trial and one was excluded after an accident. Priming started
at 9 weeks in the early (E) group (GrpE2; n = 8) and at 13 weeks of age for the late (L)
starters (GrpL3; n = 11 and GrpL2; n = 6). The booster was performed with one (GrpE2 and
L2) or two injections (GrpL3) 4 weeks apart. Animals in groups E2 and L3 had a second
vaccination cycle (2 shots) starting at 49 weeks of age (8 weeks before slaughter at 57 weeks
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of age). Animals in group L2 only had one vaccination cycle and were slaughtered at
37 weeks of age.
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Litters were only selected from animals registered in the herdbook. The Bísaro pig
is an indigenous bre d with significant genetic variability and, consequently, phenotypic
variability. Animals were from different litters and might have presented differences in the
absolute valu s at the beginning of the experiment. Comparison of the relative change in
scrotal dimensions of the three groups allows for the inference of the suppressive effects of
the vaccine on the testicular function of the treated animals.
Eleven animals were kept as intact males throughout the whole experiment (GrpC;
n = 11) to establish age-match scrotal dimensions. Animals in the control group were also
maintained until 57 weeks old.
Animals were reared indoors in groups of 5–6 animals until 29 weeks old, and there-
after in outdoor pens with approximately 1000 m2 each, and fed ad libitum. All premises
complied with the welfare requirements established in the Council Directive of 2008 [33].
The study was approved by the Animal Care and Ethical Committee of the University
of Trás-os-Montes e Alto Douro (Protocol number 657-e-DZ-2018).
2.2. Measurements
Scrotal dimensions (total width, plus the height and width of the left and right scrotal
sac) were measured every 4 weeks from the first injection (FI) until the 44th (GrpE2 and L3)
and 24th (GrpL2) week post-administration. Due to operational issues at the experimental
farm, measurements from the control group were not taken at 33 weeks old or from
groups E2 and L3 at 37 weeks old. Measurements were performed based on the Davis
and Hines method [34] using a vernier caliper. Briefly, with the animal standing, the total
width was obtained at the largest horizontal transversal axis of the scrotum, the height
of the scrotal sac was obtained at the higher vertical length of each scrotal sac, while the
maximum horizontal diameter provided the scrotal sac width. A single operator conducted
the procedures in order to minimize inter-operator biases. Animals were contained in a
specially made handling crate, where they were simultaneously weighted.
Additionally, the testis and epididymis were collected after slaughter and the testicular
and epididymal morphometric values were then taken (aggregated weight of testis and
epididymis, testis weight, width and length; epididymal weight).
Absolute dimensions from in vivo and post-mortem measurements were compared to
the expected pubertal dimensions of this specific breed [32].
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2.3. Statistical Analysis
Gonadal measurements were grouped by animal. Thus, average values for both
organs were calculated throughout the experiment [35]. The Shapiro–Wilk test was used to
assess the normality of variables of interest.
Descriptive analysis was firstly performed to characterize the evolution of the scrotal
size. The variation between each measurement in relation to the previous measurement
was calculated to survey the immunosuppressive effects of the vaccination protocols.
The variation was then compared between groups. Since the variables were not normally
distributed, group differences were identified using a Wilcoxon rank test. A confidence
level of 99% was used to minimize potential inaccuracies from in vivo measurements.
The variation in normal scrotal growth (GrpC) was also compared with the treatment
groups. A least squares model was used in the post-mortem analysis. Carcass weight and
group were included as factors. Statistical analyses were performed using JMP 7 software
(SAS Institute Inc., Cary, NC, USA).
3. Results
3.1. Absolute Dimensions of the Scrotal Sacs
Figures 2 and 3 show the scrotal sac height and width evolution throughout the study.
At the priming dose, values started at around 4 cm in height in nine-week-old animals and
increased until they were 13 weeks old (GrpE2) or 17 weeks old (GrpL2, L3 and C). After
the second administration, measurements decreased to values close to initial values in all
treated animals until weeks 17 and 21 (GrpE2 vs. GrpL2 and L3). By then, the scrotal sac
measurements increased and approximated the expected size of sexually mature animals.
This process was slower in group L3, taking almost 16 weeks. The pre-established pubertal
height and width were surpassed at 21 weeks of age in the control group, 29 weeks of
age in group E2, and 37 weeks of age in group L2. Group L3 only overtook this value at
41 weeks old. Between weeks 41 and 49, scrotal dimensions in the treated animals became
closer to those of the control group.
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From the 49th week (first dose of the second vaccination cycle), scrotal dimensions
from both treated groups decreased to values close to the predicted puberty mark. The total
scrotal width followed the same pattern (data not shown). From the 53rd week (4 weeks
after th first ad inistratio in the second vaccination cycle) until the last observation of
the study, scrotal dimensions from the control group remained high r tha in the re-treated
groups E2 and L3.
3.2. Variation of Scrotal Dimensions
Variat o of ll scrotal dimensions did not dif er signific ntly between the treatment
groups after the firs injection (p > 0.01) (4 weeks pos FI) or from the onset of the treatment
to the second administration of the vaccine, 8 week after FI (Table 1). At th 12th week post
FI, however, the variation in all the measurements differed between the groups (p ≤ 0.01),
as groups E2 and L2 were already reverting to the negative vari tion and group L3 w s
still on a negative tendency. While g oups E2 and L2 already registered a cons derab e
positive variation, group L3 still r gistered a negative variation. At 16 weeks after FI, there
were still significant differences in the variation of the scrotal sac height and scrotal sac
width (p ≤ 0.01), alth ugh les pronounced. From the 20th w ek rom FI onwards, the
predominantly positive variation in measurements became similar between the groups
(p > 0.01).
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Table 1. Mean variation of scrotal sac height and width over time (weeks after first injection).
Weeks after FI
Scrotal Sac Height Scrotal Sac Width
Grp E2 Grp L2 Grp L3 p-Value Grp E2 Grp L2 Grp L3 p-Value
4 0.38 0.20 0.48 0.020 0.47 0.26 0.61 0.216
8 −0.21 −0.22 −0.17 0.714 −0.14 −0.26 −0.11 0.053
12 0.08 b 0.33 c −0.29 a 0.001 0.13 a 0.23 a −0.26 b <0.001
16 0.69 a −0.13 b 0.04 b 0.005 0.53 0.04 0.11 0.009
20 0.26 0.16 0.24 0.674 0.37 0.09 0.17 0.073
28 0.51 0.21 1.20 0.020 0.35 0.19 1.00 0.039
32 0.07 - 0.18 0.186 −0.06 - 0.21 0.001
36 0.00 - 0.00 0.710 0.11 - −0.07 0.001
38 0.04 - - 0.00 - -
Second Vaccination Cycle
4 −0.24 - −0.23 0.934 −0.13 - −0.14 0.804
8 −0.22 - −0.17 0.509 −0.17 - −0.09 0.186
For each dimension, the different superscript letters in the same row represent significant differences between the means.
Both group E2 and group L3 inverted the positive variation after the second vaccina-
tion cycle at 49 and 53 weeks of age, respectively. Responses did not differ significantly
between the treated groups (Table 1).
3.3. Post-Mortem Morphometry
Table 2 summarizes the morphometric values taken after gonadal excision at slaughter.
The average carcass weight at slaughter of the treated animals was 117.7 kg. Animals
in group E2 were 8% and 5% heavier than animals in groups L2 and L3, respectively.
Between the three treatment groups, no significant differences were found regarding
testicular and epididymal post-mortem morphometry (p > 0.01), even though testis weight
registered the most noticeable difference (p = 0.065). Aggregated weight, testis width, and
epididymal weight differed slightly between the treated groups, but not statistically. When
comparing with the control group, the differences became evident (p < 0.01). Testicular and
epididymal dimensions were approximately 31% larger in intact animals than in treated
animals. Gonads from entire males were 66% heavier than in treated animals. Animals in
the control group also had heavier carcasses (12%).
Table 2. Comparison of post-mortem morphometry between groups (mean ± SEM) (least squares model).
Item
Group C Group E2 Group L2 Group L3
p-Value 1
n = 11 (57w) n = 8 (57w) n = 6 (37w) n = 11 (57w)
Carcass weight (kg) 132.6 ± 4.7 123.1 ± 6.1 113.0 ± 4.4 117.2 ± 3.8 0.412
Aggregated weight (g) 829.7 ± 42.5 259.6 ± 45.9 375.7 ± 48.2 227.3 ± 38.3 0.103
Testis weight (g) 314.4 ± 17.1 85.6 ± 18.5 140.0 ± 19.5 77.0 ± 15.5 0.065
Epididymal weight (g) 10.5 ± 4.6 44.3 ± 4.9 42.6 ± 5.2 36.6 ± 4.1 0.741
Testis length (cm) 12.4 ± 0.4 8.0 ± 0.5 8.5 ± 0.5 7.8 ± 0.4 0.320
Testis width (cm) 7.7 ± 0.3 5.9 ± 0.3 4.7 ± 0.3 5.6 ± 0.2 0.132
Epididimal length (cm) 20.0 ± 0.7 14.2 ± 0.7 16.0 ± 0.7 13.7 ± 0.6 0.133
Aggregated weight represents the weight of the testicle and appended structures retrieved from the visceral layer of the vaginal tunica. 1
Comparison between the treated groups only.
4. Discussion
The present assay is the first, to our knowledge, to test immunocastration protocols in
male Bísaro pigs and to demonstrate that this procedure could be an alternative method
for the castration of these animals. All tested protocols achieved a reduction in the scrotal
dimensions to pre-pubertal sizes, suggesting the success of the immunocastration process.
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A second cycle of Improvac® was needed to sustain the inhibition of the reproductive
function until slaughter, close to one year of age.
Earlier vaccination protocols have been studied and compared to the one recom-
mended by the manufacturer to enhance the suppression of reproductive function. Some of
the advantages are a distinct reduction in the reproductive organs’ size, a reduction in tes-
ticular activity and controlled boar taint [4,36]. Similarly to the results of Sladek et al. [36]
and Brunius et al. [4], in this assay, the early vaccination performed in group E2, starting at
9 weeks of age, did not interfere with the vaccine’s efficacy. For sexually precocious breeds,
like BP, this is of major importance.
For local breeds reared in non-industrial systems, keeping male pigs asexual during
an extended rearing and fattening period is imperative. Therefore, the efficacy needs
to be evaluated not only at earlier stages and at slaughter but also during the entire
growing phase after puberty, which for BP starts as early as 14 weeks old [32]. Longer
and post-pubertal protocols have been tested in autochthonous breeds, as they have
different characteristics than industrial crosses. For example, Hernandez-Garcia et al. [37]
successfully adapted a protocol for Iberian sows/gilts with three inoculations of Improvac®
at 10.5, 12, and 13.5 months, with slaughter at 16 months old. Gogic et al. [27] also
succeeded in adapting the manufacturer’s protocol to a local breed, the Mangulica; the first
vaccination was given to 275-day-old pigs and the second to approximately 320-day-old
pigs (85 and 40 days prior to slaughter, respectively). In our study, the three-dose protocol
kept gonads below pre-pubertal dimensions for a longer period of time compared to the
two dose protocol, whether it started at around two or at around three months of age.
Animals from group L2 were slaughtered earlier (37 weeks old); however, the post-mortem
morphometric analysis showed that the testicles’ dimensions stayed below or near average
pubertal values. However, for the treated groups kept in the farm, a second vaccination
cycle was needed in order to have an immunocastration effect by slaughter time. This cycle
started when the scrotal dimensions were above the predicted pubertal mark.
To evaluate the scrotal dimensions and their relationship with spermatogenesis and
puberty, we used the predicted testicular dimensions at puberty and a control group of
age-matched intact pigs. Paixão et al. [32] used post-mortem testicular measurements com-
bined with histological evaluation to create a model that inferred testicular dimensions at
the onset of puberty and sexual capability. Scrotal measurements include muscular fasciae,
membranes, skin, and variable portions of epididymal tissue, besides the testicular dimen-
sions. Therefore, surveilling the scrotum dimensions will allow to follow the changes in
testicular size in response to immunocastration. Comparing the scrotal measurements with
the predicted post-mortem testicular dimensions strengthens the information provided in
this study.
It seems that male pigs recover gonadal dimensions faster than females. With a
three-dose protocol at 19, 23, and 39 weeks old, Hernández-García et al. [37] were able
to keep female gonads at pre-pubertal dimensions until slaughter at 68 weeks of age.
This protocol kept the gilts immunocastrated for more than 6 months after the last injection.
In our assay, the dimensions from male pigs fully inverted the negative variation 4 months
after the last injection and recovered to similar gonadal dimensions of contemporaneous
entire pigs in less than 20 weeks. It also confirms that immunocastration can be reversed,
as theorized, once the antibody levels decrease to a minimum [38]. Whether or not sequela
of spermatogenesis will remain is still uncertain. To optimize the vaccine’s potential,
minimizing the costs and animal handling, other variations to the proposed protocol could
also be tested. Given the data collected in this study, in particular, the marked negative
scrotal dimension variation at 4 weeks post-FI in the second vaccination cycle, it appears
that the second administration in the second vaccination cycle could be avoided. Perhaps
it could be reserved for animals that do not respond adequately to the first injection.
The 8 week period in which the scrotal dimensions of the treated animals were close to
those of the non-treated animals could be considered a problem in alternative systems.
To overcome this issue, we could have postponed the third injection or brought forward the
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second cycle to the 33rd or 37th week of age. Data analysis shows that an effective protocol
for BP should start in 3-month-old male pigs with three injections of Improvac®, adding a
second cycle of one or two administrations at 33/37 weeks of age. This protocol would
better match the practices of the Bísaro production system, where producers seek to attain
one-year-old animals at the time of slaughter, allowing them to maintain pre-pubertal
testicular dimensions throughout most of the growing and fattening phase.
For locally bred pigs in non-industrial systems, sexual steroids are important not
only at slaughter, but also for the suppression of sexual activity during all growing and
fattening phases. Therefore, other alternatives to surgical castration, such as feeding
strategies, breeding programs, or gene editing for leveling skatole and androstenone,
seem insufficient for these particular systems. Nonetheless, steroid hormones and skatole
leveling, along with histological analysis, should be performed to confirm the efficacy
of the tested protocols. Carcass evaluation and meat quality comparison is also foreseen
to validate the absence of boar taint at slaughter. These assays will allow for a better
understanding of the protocols’ differences and how they should be implemented with
local farmers.
5. Conclusions
All tested protocols successfully reduced testicles’ sizes compared to entire animals.
For variable periods of time, dimensions were kept below those predicted in pubertal
animals. In male Bísaro pigs, the immunocastration protocol with three inoculations of
Improvac® kept testicles below pubertal dimensions for a longer period of time, implying
a more consistent and prolonged effect.
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